Dose-response relationship and within-subject variability of insulin detemir and NPH insulin in subjects with type 1 diabetes

被引：0
|
作者：
Wutte, A
Plank, J
Sinner, F
Druml, T
Sommer, R
Zdravkovic, M
Ronn, BB
Draeger, E
Pieber, TR
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A152 / A152
页数：1
相关论文
共 50 条
  • [1] Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in subjects with type 1 diabetes
    Heise, T
    Nosek, L
    Draeger, E
    Stender, A
    Ronn, BB
    Kapitza, C
    Heinemann, L
    DIABETES, 2003, 52 : A121 - A121
  • [2] Lower within-subject variability of insulin detemir compared to NPH insulin and insulin glargine in subjects with Type 1 diabetes.
    Heise, T
    Nosek, L
    Draeger, E
    Ronn, BB
    Kapitza, C
    Heinemann, L
    DIABETOLOGIA, 2003, 46 : A6 - A7
  • [3] Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes
    Heise, T
    Nosek, L
    Ronn, BB
    Endahl, L
    Heinemann, L
    Kapitza, C
    Draeger, E
    DIABETES, 2004, 53 (06) : 1614 - 1620
  • [4] Proportional dose-response relationship and lower within-patient variability of insulin deternir and NPH insulin in subjects with type 1 diabetes mellitus
    Wutte, A.
    Plank, J.
    Bodenlenz, M.
    Magnes, C.
    Regittnig, W.
    Sinner, F.
    Ronn, B.
    Zdravkovic, M.
    Pieber, T. R.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 (07) : 461 - 467
  • [5] Comparison of pharmacodynamic and pharmacokinetic dose-response profiles between insulin detemir and NPH insulin in subjects with type 2 diabetes
    Pieber, TR
    Wutte, A
    Plank, J
    Bock, G
    Magnes, C
    Bodenlenz, M
    Endahl, L
    Draeger, E
    Jacobsen, LV
    DIABETES, 2004, 53 : A142 - A142
  • [6] Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes
    Haak, T
    Tiengo, A
    Draeger, E
    Suntum, M
    Waldhäusl, W
    DIABETES OBESITY & METABOLISM, 2005, 7 (01): : 56 - 64
  • [7] Dose-response relationship of insulin glulisine in subjects with type 1 diabetes
    Becker, R. H. A.
    Frick, A. D.
    Teichert, L.
    Nosek, L.
    Heinemann, L.
    Rave, K.
    DIABETES OBESITY & METABOLISM, 2009, 11 (01): : 60 - 68
  • [8] Dose-response relationship of insulin glulisine in, subjects with type 1 diabetes
    Becker, Reinhard H. A.
    Frick, Annke D.
    Nosek, Leszek
    Heinemann, Lutz
    Rave, Klaus
    DIABETES CARE, 2007, 30 (10) : 2506 - 2507
  • [9] Lower within-subject variability in pharmacokinetic profiles of insulin detemir in comparison to insulin glargine in children and adolescents with type I diabetes
    Danne, T.
    Endahl, L.
    Haahr, H.
    Datz, N.
    Nestoris, C.
    Westergaard, L.
    Kordonouri, O.
    DIABETOLOGIA, 2007, 50 : S84 - S84
  • [10] Less glucose variability with insulin detemir compared to NPH insulin in subjects with type 1 diabetes undergoing continuous glucose monitoring
    Jones, David R.
    Clauson, Per
    Ong, Stephanie
    Mathieu, Chantal
    DIABETES, 2006, 55 : A118 - A118
12345